{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:47:19Z","timestamp":1786718839353,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neural Regen Res"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/1673-5374.213558","type":"journal-article","created":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T03:08:06Z","timestamp":1503371286000},"page":"1352","source":"Crossref","is-referenced-by-count":2,"title":["Optical coherence tomography and T cell gene expression analysis in patients with benign multiple sclerosis"],"prefix":"10.4103","volume":"12","author":[{"given":"Yang","family":"Mao-Draayer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Soltys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1673-5374.213558-1","doi-asserted-by":"crossref","unstructured":"Balk L, Tewarie P, Killestein J, Polman C, Uitdehaag B, Petzold A (2014) Disease course heterogeneity and OCT in multiple sclerosis. Mult Scler 20:1198-1206.","DOI":"10.1177\/1352458513518626"},{"key":"key-10.4103\/1673-5374.213558-2","doi-asserted-by":"crossref","unstructured":"Button J, Al-Louzi O, Lang A, Bhargava P, Newsome SD, Frohman T, Balcer LJ, Frohman EM, Prince J, Calabresi PA, Saidha S (2017) Disease-modifying therapies modulate retinal atrophy in multiple sclerosis: a retrospective study. Neurology 88:525-532.","DOI":"10.1212\/WNL.0000000000003582"},{"key":"key-10.4103\/1673-5374.213558-3","doi-asserted-by":"crossref","unstructured":"Byskosh PV, Reder AT (1996) Interferon beta-1b effects on cytokine mRNA in peripheral mononuclear cells in multiple sclerosis. Mult Scler 1:262-269.","DOI":"10.1177\/135245859600100502"},{"key":"key-10.4103\/1673-5374.213558-4","doi-asserted-by":"crossref","unstructured":"Cettomai D, Pulicken M, Gordon-Lipkin E, Salter A, Frohman TC, Conger A, Zhang X, Cutter G, Balcer LJ, Frohman EM, Calabresi PA (2008) Reproducibility of optical coherence tomography in multiple sclerosis. Arch Neurol 65:1218-1222.","DOI":"10.1001\/archneur.65.9.1218"},{"key":"key-10.4103\/1673-5374.213558-5","doi-asserted-by":"crossref","unstructured":"Correale J, Villa A (2004) The neuroprotective role of inflammation in nervous system injuries. J Neurol 251:1304-1316.","DOI":"10.1007\/s00415-004-0649-z"},{"key":"key-10.4103\/1673-5374.213558-6","doi-asserted-by":"crossref","unstructured":"Correale J, Peirano I, Romano L (2012) Benign multiple sclerosis: a new definition of this entity is needed. Mult Scler 18:210-218.","DOI":"10.1177\/1352458511419702"},{"key":"key-10.4103\/1673-5374.213558-7","doi-asserted-by":"crossref","unstructured":"Cruz-Herranz A, Balk LJ, Oberwahrenbrock T, Saidha S, Martinez-Lapiscina EH, Lagreze WA, Schuman JS, Villoslada P, Calabresi P, Balcer L, Petzold A, Green AJ, Paul F, Brandt AU, Albrecht P; IMSVISUAL consortium (2016) The APOSTEL recommendations for reporting quantitative optical coherence tomography studies. Neurology 86:2303-2309.","DOI":"10.1212\/WNL.0000000000002774"},{"key":"key-10.4103\/1673-5374.213558-8","doi-asserted-by":"crossref","unstructured":"D\u00f6rr J, Wernecke KD, Bock M, Gaede G, Wuerfel JT, Pfueller CF, Bellmann-Strobl J, Freing A, Brandt AU, Friedemann P (2011) Association of retinal and macular damage with brain atrophy in multiple sclerosis. PLoS One 6:e18132.","DOI":"10.1371\/journal.pone.0018132"},{"key":"key-10.4103\/1673-5374.213558-9","doi-asserted-by":"crossref","unstructured":"Galetta SL, Villoslada P, Levin N, Shindler K, Ishikawa H, Parr E, Cadavid D, Balcer LJ (2015) Acute optic neuritis: unmet clinical needs and model for new therapies. Neurol Neuroimmunol Neuroinflamm 2:e135.","DOI":"10.1212\/NXI.0000000000000135"},{"key":"key-10.4103\/1673-5374.213558-10","doi-asserted-by":"crossref","unstructured":"Huang-Link YM, Fredrikson M, Link H (2015) Benign multiple sclerosis is associated with reduced thinning of the retinal nerve fiber and ganglion cell layers in non-optic-neuritis eyes. J Clin Neurol 11:241-247.","DOI":"10.3988\/jcn.2015.11.3.241"},{"key":"key-10.4103\/1673-5374.213558-11","doi-asserted-by":"crossref","unstructured":"Hviid LE, Healy BC, Rintell DJ, Chitnis T, Weiner HL, Glanz BI (2011) Patient reported outcomes in benign multiple sclerosis. Mult Scler 17:876-884.","DOI":"10.1177\/1352458511398370"},{"key":"key-10.4103\/1673-5374.213558-12","doi-asserted-by":"crossref","unstructured":"Johnson MC, Pierson ER, Spieker AJ, Nielsen AS, Posso S, Kita M, Buckner JH, Goverman JM (2016) Distinct T cell signatures define subsets of patients with multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 3:e278.","DOI":"10.1212\/NXI.0000000000000278"},{"key":"key-10.4103\/1673-5374.213558-13","doi-asserted-by":"crossref","unstructured":"Kimura A, Kishimoto T (2010) IL-6: regulator of Treg\/Th17 balance. Eur J Immunol 40:1830-1835.","DOI":"10.1002\/eji.201040391"},{"key":"key-10.4103\/1673-5374.213558-14","doi-asserted-by":"crossref","unstructured":"Krakauer M, Sorensen P, Khademi M, Olsson T, Sellebjerg F (2008) Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression. Mult Scler 14:622-630.","DOI":"10.1177\/1352458507087136"},{"key":"key-10.4103\/1673-5374.213558-15","doi-asserted-by":"crossref","unstructured":"Lange AP, Zhu F, Sayao AL, Sadjadi R, Alkabie S, Traboulsee AL, Costello F, Tremlett H (2013) Retinal nerve fiber layer thickness in benign multiple sclerosis. Mult Scler 19:1275-1281.","DOI":"10.1177\/1352458512474706"},{"key":"key-10.4103\/1673-5374.213558-16","doi-asserted-by":"crossref","unstructured":"Martinez-Lapiscina EH, Arnow S, Wilson JA, Saidha S, Preiningerova JL, Oberwahrenbrock T, Brandt AU, Pablo LE, Guerrieri S, Gonzalez I, Outteryck O, Mueller AK, Albrecht P, Chan W, Lukas S, Balk LJ, Fraser C, Frederiksen JL, Resto J, Frohman T, et al. (2016) Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study. Lancet Neurol 15:574-584.","DOI":"10.1016\/S1474-4422(16)00068-5"},{"key":"key-10.4103\/1673-5374.213558-17","doi-asserted-by":"crossref","unstructured":"Melamed E, Levy M, Waters PJ, Sato DK, Bennett JL, John GR, Hooper DC, Saiz A, Bar-Or A, Kim HJ, Pandit L, Leite MI, Asgari N, Kissani N, Hintzen R, Marignier R, Jarius S, Marcelletti J, Smith TJ, Yeaman MR, et al. (2015) Update on biomarkers in neuromyelitis optica. Neurol Neuroimmunol Neuroinflamm 2:e134.","DOI":"10.1212\/NXI.0000000000000134"},{"key":"key-10.4103\/1673-5374.213558-18","doi-asserted-by":"crossref","unstructured":"Metcalfe SM, Strom TB, Williams A, Fahmy TM (2015) Multiple sclerosis and the LIF\/IL-6 axis: use of nanotechnology to harness the tolerogenic and reparative properties of LIF. Nanobiomedicine 2:5.","DOI":"10.5772\/60622"},{"key":"key-10.4103\/1673-5374.213558-19","doi-asserted-by":"crossref","unstructured":"Oberwahrenbrock T, Schippling S, Ringelstein M, Kaufhold F, Zimmermann H, Keser N, Young KL, Harmel J, Hartung HP, Martin R, Paul F, Aktas O, Brandt AU (2012) Retinal damage in multiple sclerosis disease subtypes measured by high-resolution optical coherence tomography. Mult Scler Int 2012:530305.","DOI":"10.1155\/2012\/530305"},{"key":"key-10.4103\/1673-5374.213558-20","unstructured":"Patella VM (2010) Stratus OCT: Establishment of normative reference values for retinal nerve fiber layer thickness measurements. Carl Zeiss Meditec Web site. Available at: http:\/\/www.meditec.zeiss.de\/88256DE3007B916B\/0\/55B63359D850E15D882575E7000AA4AE\/$file\/stratusoct5_en.pdf. Accessed February 27, 2010."},{"key":"key-10.4103\/1673-5374.213558-21","doi-asserted-by":"crossref","unstructured":"Ramsaransing GS, De Keyser J (2006) Benign course in multiple sclerosis: a review. Acta Neurol Scand 113:359-369.","DOI":"10.1111\/j.1600-0404.2006.00637.x"},{"key":"key-10.4103\/1673-5374.213558-22","doi-asserted-by":"crossref","unstructured":"Saidha S, Syc SB, Durbin MK, Eckstein C, Oakley JD, Meyer SA, Conger A, Frohman TC, Newsome S, Ratchford JN, Frohman EM, Calabresi PA (2011) Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler 17:1449-1463.","DOI":"10.1177\/1352458511418630"},{"key":"key-10.4103\/1673-5374.213558-23","doi-asserted-by":"crossref","unstructured":"Sayao AL, Bueno AM, Devonshire V, Tremlett H (2011) The psychosocial and cognitive impact of longstanding 'benign' multiple sclerosis. Mult Scler 17:1375-1383","DOI":"10.1177\/1352458511410343"},{"key":"key-10.4103\/1673-5374.213558-24","doi-asserted-by":"crossref","unstructured":"Sergott RC, Bennett JL, Rieckmann P, Montalban X, Mikol D, Freudensprung U, Plitz T, van Beek J; ATON Trial Group (2015) ATON: results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis. J Neurol Sci 351(1-2):174-178.","DOI":"10.1016\/j.jns.2015.02.019"},{"key":"key-10.4103\/1673-5374.213558-25","unstructured":"Soltys J, Knight J, Scharf E, Pitt D, Mao-Draayer Y (2014) IFN-\u03b2 alters neurotrophic factor expression in T cells isolated from multiple sclerosis patients - implication of novel neurotensin\/NTSR1 pathway in neuroprotection. Am J Transl Res 6:312-319."},{"key":"key-10.4103\/1673-5374.213558-26","doi-asserted-by":"crossref","unstructured":"Syc SB, Saidha S, Newsome SD, Ratchford JN, Levy M, Ford E, Crainiceanu CM, Durbin MK, Oakley JD, Meyer SA, Frohman EM, Calabresi PA (2012) Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain 135(Pt 2):521-533.","DOI":"10.1093\/brain\/awr264"},{"key":"key-10.4103\/1673-5374.213558-27","doi-asserted-by":"crossref","unstructured":"Wang Q, Chuikov S, Taitano S, Wu Q, Rastogi A, Tuck SJ, Corey JM, Lundy SK, and Mao-Draayer Y (2015) Dimethyl fumarate protects neural stem\/progenitor cells and neurons from oxidative damage through Nrf2-ERK1\/2 MAPK pathway. Int J Mol Sci 16:13885-13907.","DOI":"10.3390\/ijms160613885"},{"key":"key-10.4103\/1673-5374.213558-28","doi-asserted-by":"crossref","unstructured":"Wang Q, Mao-Draayer Y (2015) Neuroprotective effect of IFN-\u03b2 treatment is involved in neurotrophic factors and novel NT\/NTSR1 pathway. Neural Regen Res 10:1932-1933.","DOI":"10.4103\/1673-5374.169636"},{"key":"key-10.4103\/1673-5374.213558-29","doi-asserted-by":"crossref","unstructured":"Zimmermann H, Freing A, Kaufhold F, Gaede G, Bohn E, Bock M, Oberwahrenbrock T, Young KL, D\u00f6rr J, Wuerfel JT, Schippling S, Paul F, Brandt AU (2013) Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations. Mult Scler 19:443-150.","DOI":"10.1177\/1352458512457844"},{"key":"key-10.4103\/1673-5374.213558-30","doi-asserted-by":"crossref","unstructured":"Zivadinov R, Cookfair DL, Krupp L, Miller AE, Lava N, Coyle PK, Goodman AD, Jubelt B, Lenihan M, Herbert J, Gottesman M, Snyder DH, Apatoff BR, Teter BE, Perel AB, Munschauer F, Weinstock-Guttman B (2016) Factors associated with benign multiple sclerosis in the New York State MS Consortium (NYSMSC). BMC Neurol 16:102.","DOI":"10.1186\/s12883-016-0623-2"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:40:23Z","timestamp":1786714823000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.213558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017]]}},"alternative-id":["213558"],"URL":"https:\/\/doi.org\/10.4103\/1673-5374.213558","relation":{},"ISSN":["1673-5374"],"issn-type":[{"value":"1673-5374","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}